XML 15 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Capital Surplus [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Deferred Benefits for Directors [Member]
Beginning Balance at Dec. 31, 2016 $ 1,341,408 $ 91,524 $ 680,507 $ 597,071   $ (27,126) $ (568)
Beginning Balance, shares at Dec. 31, 2016   43,931,715          
Net income 52,228     52,228      
Other comprehensive income 5,008         5,008  
Comprehensive income 57,236            
Common dividends declared (22,878)     (22,878)      
Treasury shares acquired (488)       $ (488)    
Treasury shares acquired, shares   (12,987)          
Stock options exercised 1,061 $ 75 883   103    
Stock options exercised, shares   38,584          
Restricted stock granted   $ 154 (154)        
Restricted stock granted, shares   74,023          
Stock compensation expense 1,198   1,198        
Deferred benefits for directors - net     9       (9)
Ending Balance at Jun. 30, 2017 1,377,537 $ 91,753 682,443 626,421 (385) (22,118) (577)
Ending Balance, shares at Jun. 30, 2017   44,031,335          
Beginning Balance at Dec. 31, 2017 1,395,321 $ 91,756 684,730 651,357   (31,495) (1,027)
Beginning Balance, shares at Dec. 31, 2017   44,043,244          
Net income 66,698     66,698      
Other comprehensive income (20,794)         (20,794)  
Comprehensive income 45,904            
Common dividends declared (26,298)     (26,298)      
Adoption of accounting standard ASU 2016-01       1,063   (1,063)  
Shares issued for acquisition 107,347 $ 5,206 102,141        
Shares issued for acquisition, shares   2,498,761          
Treasury shares acquired (680)   34   (714)    
Treasury shares acquired, shares   (15,159)          
Stock options exercised 1,143 $ 69 915   159    
Stock options exercised, shares   36,788          
Restricted stock granted   $ 166 (166)        
Restricted stock granted, shares   79,616          
Stock compensation expense 1,838   1,838        
Deferred benefits for directors - net (469)   (454)       (15)
Ending Balance at Jun. 30, 2018 $ 1,524,106 $ 97,197 $ 789,038 $ 692,820 $ (555) $ (53,352) $ (1,042)
Ending Balance, shares at Jun. 30, 2018   46,643,250